METTL13在肿瘤中的研究进展
Progress of METTL13 Research in Tumors
DOI: 10.12677/ACM.2022.125714, PDF,   
作者: 刘玉婵：青海大学研究生院，青海 西宁；杨勇莉, 李 研：青海大学附属医院，青海 西宁
关键词: METTL13；FEAT蛋白；miR-16；肿瘤；METTL13； FEAT Protein； miR-16； Tumour
摘要: 蛋白质甲基转移酶样13 (METTL13)编码蛋白质Faint expression innormal tissues，aberrant over-expression in tumors (FEAT)，位于染色体1q24.3，具有双甲基转移酶的特性。在大多数人类癌症中异常高表达，但在正常组织中弱表达。miR-16是FEAT的直接调节因子，miR-16直接识别并结合FEAT mRNA转录本的3’-UTR，从而抑制FEAT翻译。研究表明，FEAT在体内具有高度致癌作用。METTL13的异常调节与几种类型的癌症有关，但其确切机制尚不完全清楚。GEO图谱数据库中的全基因组连锁分析表明，人类METTL13基因的遗传变异与肿瘤恶性程度、肿瘤转移、癌症进展、化疗敏感性和微卫星不稳定性有关。本文系统回顾了与METTL13相关文献，就METTL13在肿瘤中的研究进展作一综述。
Abstract: The protein methyltransferase-like 13 (METTL13) encodes the protein Faint expression in normal tissues, aberrant overexpression in tumors (FEAT), located on chromosome 1q24.3, with dual me-thyltransferase properties. It is aberrantly highly expressed in most human cancers but weakly ex-pressed in normal tissues. miR-16 is a direct regulator of FEAT, and miR-16 directly recognizes and binds to the 3’-UTR of FEAT mRNA transcripts, thereby inhibiting FEAT translation. Studies have shown that FEAT is highly oncogenic in vivo. Aberrant regulation of METTL13 has been associated with several types of cancer, but the exact mechanism is not fully understood. Genome-wide linkage analysis in the GEO Atlas database suggests that genetic variation in the human METTL13 gene is associated with tumor malignancy, tumor metastasis, cancer progression, chemotherapy sensitivity, and microsatellite instability. In this paper, we systematically review the literature related to METTL13 and present a review on the progress of METTL13 research in tumors.
文章引用：刘玉婵, 杨勇莉, 李研. METTL13在肿瘤中的研究进展[J]. 临床医学进展, 2022, 12(5): 4924-4928. https://doi.org/10.12677/ACM.2022.125714

参考文献

[1] Takahashi, A., Tokita, H., Takahashi, K., Takeoka, T., Murayama, K., Tomotsune, D., Ohira, M., Iwamatsu, A., Ohara, K., Yazaki, K., et al. (2011) A Novel Potent Tumour Promoter Aberrantly Overexpressed in Most Human Cancers. Sci-entific Reports, 1, Article No. 15. [Google Scholar] [CrossRef] [PubMed]
[2] Kim, J., et al. (2010) AMyc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs. Cell, 143, 313-324. [Google Scholar] [CrossRef] [PubMed]
[3] Liang, H., Fu, Z., Jiang, X., Wang, N., Wang, F., Wang, X., Zhang, S., Wang, Y., Yan, X., Guan, W.X., et al. (2015) miR- 16 Promotes the Apoptosis of Human Cancer Cells by Targeting FEAT. BMC Cancer, 15, Article No. 448. [Google Scholar] [CrossRef] [PubMed]
[4] Calin, G.A., Dumitru, C.D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., et al. (2002) Frequent Deletions and Down- Regulation of Micro-RNA Genes miR15 and miR16 at13q14 in Chronic Lymphocytic Leukemia. Proceedings of the National Academy of Sciences of the United States of America, 99, 15524-15529. [Google Scholar] [CrossRef] [PubMed]
[5] Liu, Q., Fu, H., Sun, F., Zhang, H., Tie, Y., Zhu, J., et al. (2008) miR-16 Family Induces Cellcycle Arrest by Regulating Multiple Cell Cycle Genes. Nucleic Acids Research, 36, 5391-5404. [Google Scholar] [CrossRef] [PubMed]
[6] Li, Y., Kobayashi, K., Mona, M.M., Satomi, C., Okano, S., Inoue, H., Tani, K. and Takahashi, A. (2016) Immunogenic FEAT Protein Circulates in the Bloodstream of Cancer Pa-tients. Journal of Translational Medicine, 14, Article No. 275. [Google Scholar] [CrossRef] [PubMed]
[7] Clarke, S.G. (2013) Protein Methylation at the Surface and Bur-ied Deep: Thinking outside the Histone Box. Trends Biochem. Sci, 38, 243-252. [Google Scholar] [CrossRef] [PubMed]
[8] Jakobsson, M.E., Małecki, J., Halabelian, L., Nilges, B.S., Pinto, R., Kudithipudi, S., Munk, S., Davydova, E., Zuhairi, F.R., Arrowsmith, C., et al. (2018) The Dual Methyltransferase METTL13 Targets N Terminus and Lys55 of eEF1A and Modulates Codonspecific Translation Rates. Nature Commu-nications, 9, Article No. 3411. [Google Scholar] [CrossRef] [PubMed]
[9] Garraway, L.A. and Lander, E.S. (2013) Lessons from the Cancer Genome. Cell, 153, 17-37. [Google Scholar] [CrossRef] [PubMed]
[10] Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
[11] Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz Jr., L.A. and Kinzler, K.W. (2013) Cancer Genome Landscapes. Science, 339, 1546-1558. [Google Scholar] [CrossRef] [PubMed]
[12] Li, Y., Kobayashi, K., Murayama, K., Kawahara, K., Shima, Y., Su-zuki, A., Tani, K. and Takahashi, A. (2018) FEAT Enhances INSL3 Expression in Testicular Leydig Cells. Genes to Cells, 23, 952-962. [Google Scholar] [CrossRef] [PubMed]
[13] Zhang, Z., Zhang, G., Kong, C., et al. (2016) METTL13 Is Downregulated in Bladder Carcinoma and Suppresses Cell Proliferation, Migration and Invasion. Scientific Reports, 6, Article No. 19261. [Google Scholar] [CrossRef] [PubMed]
[14] Liu, Z., Sun, T., Piao, C., Zhang, Z. and Kong, C. (2021) METTL13 Inhibits Progression of Clear Cell Renal Cell Carcinoma with Repression on PI3K/AKT/mTOR/HIF-1α Pathway and c-Mycexpression. Journal of Translational Medicine, 19, Article No. 209. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, S.M., Ye, M., Zhou, J., Ni, S.M. and Wei, Q.C. (2017) FEAT Expression Correlates with Tumor Size, PR Status, HER2 Expression, Ki67 Index, and Molecular Subtype and Predicts Recurrence in Breast Cancer. Neoplasma, 64, 123-130. [Google Scholar] [CrossRef] [PubMed]
[16] Liu, S., Hausmann, S., Carlson, S.M., Fuentes, M.E., Francis, J., Pillai, R., Lofgren, S.M., Hulea, L., Tandoc, K., Lu, J., et al. (2019) METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis. Cell, 176, 491-504.E21. [Google Scholar] [CrossRef] [PubMed]
[17] Li, L., Zheng, Y.L., Jiang, C., et al. (2019) HN1L-Mediated Transcriptional Axis AP-2γ/METTL13/TCF3-ZEB1 Drives Tumor Growth and Metastasis in Hepato-cellular Carcinoma. Cell Death & Differentiation, 26, 2268-2283. [Google Scholar] [CrossRef] [PubMed]
[18] Su, X.F., Li, N., Meng, F.L., Chu, Y.L., Li, T. and Gao, X.Z. (2019) MiR-16 Inhibits Hepatocellular Carcinoma Progression by Targeting FEAT through NF-κB Signaling Pathway. European Review for Medical and Pharmacological Sciences, 23, 10274-10282.
[19] Wang, X., Li, K., Wan, Y., Chen, F., Cheng, M., Xiong, G., Wang, G., Chen, S., Chen, Z., Chen, J., et al. (2021) Methyltransferase Like 13 Mediates the Translation of Snail in Head and Neck Squamous Cell Carcinoma. International Journal of Oral Science, 13, Article No. 26. [Google Scholar] [CrossRef] [PubMed]
[20] Yousaf, R., Ahmed, Z.M., Giese, A.P., Morell, R.J., Lagziel, A., Dabdoub, A., Wilcox, E.R., Riazuddin, S., Friedman, T.B. and Riazuddin, S. (2018) Modifier Variant of METTL13 Suppresses Human GAB1-Associated Profound Deafness. Journal of Clinical Investigation, 128, 1509-1522. [Google Scholar] [CrossRef] 

为你推荐